🎙️ We’re back with the third episode of Parkinson Weekly, hosted by Prof. Bas Bloem.
This week’s Article of the Week explores an exciting area of research:
“Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson’s disease in the UK: a phase 2, multi-centre, double-blind, parallel-group, randomised, placebo-controlled trial.”
👉 You can read the full article here: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02808-3/fulltext & https://pubmed.ncbi.nlm.nih.gov/39919773/
Tune in to hear Prof. Bloem break down the findings and what they could mean for the Parkinson’s community.
And dont forget, you can listen here:
Amazon Music: https://music.amazon.co.uk/podcasts/34ec09bc-c8b8-4a28-a12b-ca8aae3edd57/parkinson-weekly?ref=dm_sh_BpcE171Aj6Bvc6jQNKL90yl8o
Spotify: https://open.spotify.com/show/5FVqV671ESQ5VxbncsIxIS?si=a29cb8d5e72640de
Apple: https://podcasts.apple.com/gb/podcast/parkinson-weekly/id1836115672
Have a question you’d like Bas to answer in a future episode? Email us at parkinsonweekly@gmail.com – we’d love to hear from you.